TY  - GEN
AU  - Perez de Llano, Luis Alejandro
AU  - García-Cosío, Borja
AU  - Astiarraga, Ignacio Lobato
AU  - Campos, Gregorio Soto
AU  - Alonso, Miguel Angel Tejedor
AU  - Malanda, Nuria Marina
AU  - Padilla Galo, Alicia
AU  - Landa, Isabel Urrutia
AU  - de la Rosa, Francisco J. Michel
AU  - Garcia-Moguel, Ismael
AU  - Reslizumab Real Life
PY  - 2022
DO  - 10.2147/JAA.S340562
SN  - 1178-6965
UR  - https://hdl.handle.net/20.500.12105/23389
AB  - Background: Reslizumab is an anti-interleukin 5 monoclonal antibody that has demonstrated to reduce the risk of severe exacerbations and to improve symptoms, lung function, and quality of life in randomized controlled trials that included patients...
LA  - eng
PB  - Dove Medical Press
KW  - Eosinophilic asthma
KW  - Reslizumab
KW  - Asthma control
KW  - Monoclonal antibodies
TI  - Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life Data
TY  - research article
ER  -